<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02448875</url>
  </required_header>
  <id_info>
    <org_study_id>TMI-13-01</org_study_id>
    <nct_id>NCT02448875</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of Visco-Assisted CyPass Micro-Stent Implantation in Patients With Open Angle Glaucoma</brief_title>
  <acronym>ViscoPass</acronym>
  <official_title>A Randomized, Prospective Clinical Evaluation of the Safety and Effectiveness of Visco-Assisted CyPass Micro-Stent Implantation in Patients With Open Angle Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Transcend Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to assess the safety and effectiveness of the use of visco-assisted CyPass
      Micro-Stent implantation for the lowering of intraocular pressure (IOP) in patients who have
      open angle glaucoma (OAG).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2013</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of eyes with =&gt; 20% decrease in IOP without use of ocular hypotensive medication</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Device-related ocular adverse events</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in unmedicated IOP from baseline</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of eyes using ocular hypotensive medication</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean number of topical IOP-lowering medications used</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">192</enrollment>
  <condition>Open Angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>CyPass Micro-Stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in this arm of the study will receive the CyPass Micro-Stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CyPass Micro-Stent + 60 ul viscoelastic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in this arm of the study will receive the CyPass Micro-Stent followed by targeted delivery of ophthalmic viscoelastic to expand the aqueous drainage area created by the CyPass device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CyPass Micro-Stent</intervention_name>
    <description>The CyPass Micro-Stent is a small tube with a through-lumen designed to redirect aqueous fluid from the front to the back of the eye in order to reduce intraocular pressure. The CyPass Micro-Stent is designed to be permanently implanted in the eye.</description>
    <arm_group_label>CyPass Micro-Stent</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CyPass Micro-Stent + 60 ul viscoelastic</intervention_name>
    <description>In addition to CyPass Micro-Stent implantation, 60 ul of ophthalmic viscoelastic will be used to increase the size of the aqueous drainage area created by the CyPass Micro-Stent</description>
    <arm_group_label>CyPass Micro-Stent + 60 ul viscoelastic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of open angle glaucoma;

          -  unmedicated IOP between 21 - 36 mmHg, inclusive;

          -  normal angle anatomy at site of intended CyPass Micro-Stent implantation

        Exclusion Criteria:

          -  Advanced glaucoma;

          -  prior incisional glaucoma surgery;

          -  acute angle closure, traumatic, congenital, malignant, uveitic or neovascular
             glaucoma;

          -  clinically significant ocular pathology other than glaucoma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vice President of Medical Affairs</last_name>
    <role>Study Chair</role>
    <affiliation>Transcend Medical, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Lubeck</name>
      <address>
        <city>Lubeck</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsmedizin Mainz Augenklinik</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augenklinik im Dietrich-Bonhoeffer Klinikum</name>
      <address>
        <city>Neubrandenburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica des Ojos Orillac-Calvo</name>
      <address>
        <city>Panama City</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Military Medical Institute</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Panama</country>
    <country>Poland</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2015</study_first_submitted>
  <study_first_submitted_qc>May 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2015</study_first_posted>
  <last_update_submitted>July 12, 2017</last_update_submitted>
  <last_update_submitted_qc>July 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

